ABSTRACT: Hypoxic-ischemic (HI) brain injury is a major cause of neurological abnormalities in the perinatal period. Inflammation contributes to the evolution of HI brain injury. Inter-alpha inhibitor proteins (IAIPs) are a family of proteins that are part of the innate immune system. We have reported that endogenous IAIPs exhibit developmental changes in ovine brain and that exogenous IAIP treatment reduces neuronal death in HI neonatal rats. However, the effects of HI on endogenous IAIPs in brain have not been previously examined. In this study, we examined the effects of ischemiareperfusion on endogenous IAIPs levels in fetal sheep brain. Cerebral cortex, cerebellum, cervical spinal cord, choroid plexus, and CSF were snap frozen from sham control fetuses at 127 days gestation and after 30-min of carotid occlusion and 4-, 24-, and 48-h of reperfusion. IAIP levels were determined by Western immunoblot. IAIP expressions of the 250 kDa Inter-alpha inhibitor (IaI) and 125 kDa Pre-alpha inhibitor (PaI) in cerebral cortex and PaI in cerebellum were reduced (p < 0.05) 4-h after ischemia compared with controls and returned toward control levels 24-and 48-h after ischemia. CSF PaI and IaI were reduced 48 h after ischemia. We conclude that IAIPs in cerebral cortex and cerebellum are reduced by brain ischemia, and return toward control levels between 24 and 48 h after ischemia. However, changes in CSF IAIPs were delayed, exhibiting decreases 48 h after ischemia. We speculate that the decreases in endogenous IAIPs reflect increased utilization, potentially suggesting that they have endogenous neuroprotective properties.
INTRODUCTION
Hypoxic-ischemic (HI) brain injury is the one of the most common neurological problems occurring in the perinatal period (Vannucci and Hagberg, 2004; Volpe, 2009) . Recent studies suggest that fetal inflammation is a strong predictor of perinatal brain injury both in full term and premature infants and that pro-inflammatory cytokines are important in the evolution of ischemic brain injury (Ferriero, 2004; Dammann and Leviton, 2014) .
Inter-alpha-inhibitor proteins (IAIPs) are a family of proteins that are part of the innate immune system and demonstrate substantial anti-inflammatory properties (Fries and Kaczmarczyk, 2003) . They are a complex of serine protease inhibitor proteins (125 and 250 kDa) synthesized mainly in the liver and are present in plasma at high concentrations in adults and neonates (Opal et al., 2007; Chaaban et al., 2009; Chaaban et al., 2010; Spasova et al., 2014) . The two major forms, found in human plasma are Inter-alpha Inhibitor (IaI), consisting of two heavy chains (H1 and H2) and a single light chain termed bikunin (or urinary trypsin inhibitor, 30kDa), and Pre-alpha Inhibitor (PaI), which consists of one heavy (H3) and one light chain (bikunin). IaI and PaI are the most abundant bikunin-containing molecules that are found in circulating blood.
Recently, we have identified the presence of IAIPs in brain, choroid plexus, cerebral spinal fluid (CSF), and in somatic organs over a wide span of ovine development (Spasova et al., 2014) . IAIPs exhibited unique ontogenic patterns of expression specific for each major isoform and organ during development (Spasova et al., 2014) . In addition, we reported endogenous IAIP genes and proteins in cultured mouse neurons and immunoreactivity in neurons, microglia and astrocytes in isolated cultured neonatal rat cerebral cortical cells. IAIP immunoreactivity was also identified in discrete brain regions including cerebral cortex, hippocampus, ependyma, choroid plexus, and microvessels in neonatal rats and specifically in neurons, microglia cells, and astrocytes in paraffin embedded sections from fetal and neonatal rodent brain (Chen et al., 2016) . The ubiquitous nature of the expression of endogenous IAIP genes and proteins in a variety of brain cells and regions in mouse and rat central nervous system (CNS) both in vitro and in vivo supports our contention that endogenous IAIPs represent previously unrecognized important components of normal brain composition and most likely function (Spasova et al., 2014; Chen et al., 2016) . These findings are also consistent with previous work suggesting that IAIP related molecules are important in CNS inflammatory disorders such as multiple sclerosis and stroke (Yano et al., 2003; Kashyap et al., 2009; Shu et al., 2011; Shu et al., 2015) . A recent report has suggested that CSF urinary trypsin inhibitor (light chain of IAIPs) levels were lower in patients with multiple sclerosis than in control subjects, and that CSF urinary trypsin inhibitor levels predict the severity of demyelination (Shu et al., 2015) . Furthermore, systemic inflammatory disorders such as sepsis and necrotizing enterocolitis (NEC) result in decreased IAIP blood levels in premature infants (Chaaban et al., 2009; Chaaban et al., 2010) .
Therefore, endogenous IAIPs have been shown to be expressed in the brain over a wide developmental period in sheep, and in fetal and neonatal rodents, are decreased in blood of premature infants after systemic inflammation, and urinary trypsin inhibitor levels are decreased in CSF of adults with inflammatory CNS disorders (Chaaban et al., 2009; Chaaban et al., 2010; Shu et al., 2011; Spasova et al., 2014; Shu et al., 2015) . Importantly, inflammation is a critical component in the evolution of HI brain injury in neonates (Ferriero, 2004) . Consequently, the potential exists that IAIPs represent important endogenous neuroprotective molecules (Spasova et al., 2014) . However, the effects of ischemia and reperfusion on endogenous IAIPs in brain have not been previously examined. In an effort to elucidate, the effects of ischemia-reperfusion on these endogenous proteins in brain, we examined the effects of ischemia and different durations of reperfusion on IAIP levels in fetal sheep plasma, cerebral cortical, cerebellar, cervical spinal cord, choroid plexus, and CSF samples.
METHODS
The present study was performed after approval by the Institutional Animal Care and Use Committees of The Alpert Medical School of Brown University and Women & Infants Hospital of Rhode Island and in accordance to the National Institutes of Health Guidelines for the use of experimental animals.
Animal Preparation and Experimental Design
The plasma, cerebral cortical, cerebellar, cervical spinal cord, choroid plexus, and CSF samples for the present study were obtained from fetal sheep studied in our former work (Chen et al., 2012) . The surgical and physiological procedures were performed for our previous studies as described in detail (Chen et al., 2012) . In brief, surgery was performed under 1-2% isoflurane anesthesia on mixed breed pregnant ewes at 120-122 days of gestation. Catheters were placed in fetal brachial veins and arteries and in the femoral artery of the ewe for blood pressure and heart rate monitoring and to obtain blood samples for our earlier study (Chen et al., 2012) . Two inflatable 4-mm vascular occluders (In Vivo Metric, Healdsburg, CA, USA) were placed around each carotid artery along with ultrasonic flow probes (Transonic Systems Inc., Ithaca, NY, USA). Our previous study had been designed to quantify blood-brain barrier permeability under conditions of ischemia with differing durations of reperfusion (Chen et al., 2012) . The fetal sheep were studied at 85% of gestation (125-128 days of gestation). Full term gestation in this breed of sheep is 145-147 days. The sheep brain at 85% gestation is generally thought to be similar to those of the term equivalent human infants (Barlow, 1969; Back et al., 2006) . Samples were obtained from sham operated control (n 5 5) and fetal sheep exposed to 30-minutes of carotid occlusion and 4 (n 5 5), 24 (n 5 5), and 48 (n 5 5) h of reperfusion. At the end of the studies, a CSF sample was obtained from the fetal sheep via a direct puncture of the allantoic membrane. The CSF sample was inspected for blood contamination and discarded if contamination was present. All samples were obtained at the end of the studies immediately before euthanasia (Chen et al., 2012) . Regional brain, CSF, and plasma samples were snap frozen in liquid nitrogen and remained at 280 C until analysis.
Competitive Enzyme-Linked Immunosorbent Assay (ELISA) to Measure IAIPs in Ovine Plasma
Plasma samples from the fetal sheep in the control group and in the groups exposed to ischemia and 4, 24, and 48 h of reperfusion were obtained before and serially after exposure to the ischemic insult. Plasma IAIPs concentrations were measured with a competitive ELISA in sheep plasma using a polyclonal antibody raised against human IAIPs (R-20 pAb) as we previously described (Spasova et al., 2014) . The polyclonal antibody was generated by immunizing rabbits with purified human plasma derived IAIPs . The R-20 pAb cross-reacts with non-human IAIPs including sheep and detects both the 250 kDa IaI and 125 kDa PaI protein moieties in the Western immunoblot analysis. The R-20 pAb also binds to heavy chains as well as light chain of human IAIPs after enzymatic digestion . Ninety-six-well high-binding microplates (Microlon 600, Greiner Bio-One, Monroe, NC, USA) were coated with purified sheep IAIPs. The sheep IAIPs were purified from sheep serum (Quad Five, Ryegate, MO, USA) by anion-exchange chromatography on a Toyopearl Q-600C-AR column (Tosoh Bioscience, King of Prussia, PA, USA). Bound IAIPs were eluted with a buffer containing 750 mM NaCl. Purified sheep IAIPs were diluted in 100 mM NaPO 4 buffer pH 6.5 and immobilized on the microplates (50 ng/per well) for 1 h at room temperature or overnight at 4 C. The microplate was blocked with 200 mL of 5% non-fat dried milk in phosphate buffered saline (PBS) and 0.05% Tween. Known amounts of purified sheep IAIPs were serially diluted in PBS to establish the standard curve for quantitative analysis of IAIPs concentrations in the samples. After 50 mL of samples and serially diluted IAIPs standards were added to the wells, 50 mL of R-20 pAb diluted in 1:1200 in PBS was added to each well. Plates were incubated for 1 h at room temperature and washed with PBS and 0.05% Tween using automated plate washer (Biotek EL-404, Winooski, VT,USA). The bound R-20 pAb was detected by adding HRP-conjugated goat anti-rabbit IgG (Invitrogen, Carlsbad, CA, USA) for 1 h at room temperature. After washing, 100 mL Enhanced KBlue TMB substrate (Neogen Corp, Lexington, KY, USA) was added to the wells and reaction was stopped with 100 mL 1 N HCL solution. The absorbance at 450 nm was measured on SpectraMAX Plus microplate reader (Molecular Devices, Sunnyvale, CA, USA). Each sample was measured in triplicate and assays were repeated at least twice on all samples.
Preparation of Cytosolic Tissue Fractions
Cytosolic cellular fractions of cerebral cortex, cerebellum, spinal cord, and choroid plexus for IAIPs were extracted in buffer A (TRIS 10 mM pH 6.8, sucrose, MgCl 2 ) with 1% complete protease inhibitor cocktail (Sigma, St. Louis, MO, USA). Total protein concentrations of the homogenates were measured with a bicinchoninic acid protein assay (BCA, Pierce, Rockford, IL, USA). Aliquots of extracted samples were stored at 2808C. We determined IAIPs in the cytosolic fraction because the primary antibody R-20 recognized only proteins in the cytosol.
Western Immunoblot Detection and Quantification of IAIPs Proteins
Fifteen mg protein of total protein per well from each brain region were fractionated on SDS-polyacrylamide gels. Five ml of CSF were used. The gels were then transferred on to polyvinylidene diflouride membranes (PVDF, 0.2 lm, BioRad Laboratories, Hercules, CA) using a semi-dry technique. The membranes were incubated with rabbit polyclonal antibody against human IAIPs (R-20 pAb, ProThera Biologics, Providence RI, USA) at a dilution of 1:5,000. The immunoblot membranes were incubated with primary antibody at 48C overnight. Peroxidase-labeled secondary goat anti-rabbit antibody (Alpha Diagnostic, San Antonio, TX, USA) was incubated for 1 h at room temperature in a dilution of 1:10,000. Binding of the secondary antibody was detected with enhanced chemiluminescence (ECL plus, Western Blotting Detection reagents, Amersham Pharmacia Biotech, Inc., Piscataway, NJ, USA) before exposure to autoradiography film (Daigger, Vernon Hills, IL, USA).
The samples were normalized to a reference protein standard that was obtained from a homogenate protein pool from the brain of one adult sheep. For the purpose of the current report, we refer to these samples as the internal control protein samples. As we previously described (Kim et al., 2006; Malaeb et al., 2007; Sadowska et al., 2009; Spasova et al., 2014) , these internal control samples served as controls for quality of loading, transfer of the samples, normalization of the densitometric values, and permitted accurate comparisons among the different immunoblots (Kim et al., 2006; Malaeb et al., 2007; Spasova et al., 2014) . The use of the internal control protein samples permit comparisons among large groups of animals and over a large number of different immunoblots. The experimental autoradiographic integrated optical density (IOD) values were expressed as a ratio to the internal control and enabled normalized comparisons among the groups. This methodology correlates well with values that were normalized as ratios to b-actin and vinculin (Kim et al., 2006; Sadowska et al., 2015) . Each immunoblot included samples from the four groups and three internal control samples. The internal control samples were included in three lanes, as the first, middle, and last samples on each immunoblot. We calculated a coefficient of variation for the internal control samples on each immunoblot. The experimental values were accepted as valid only when the percent coefficient of variation for the internal control samples was less than 20% on the immunoblot. Human plasma-derived IAIPs served as a positive control for all immunoblots to ascertain that the antibody correctly identified the ovine proteins. Molecular weight standards (Bio-Rad Laboratories, Hercules, CA, USA) were also included in each immunoblot. The R-20 pAb detected IAIPs bands at 125 and 250 kDa (PaI and IaI) in all brain regions. Uniformity in inter lane loading was also established by Coomassie blue (Sigma, St. Louis, MO, USA) staining of the polyacrylamide gels and uniformity of transfer to the polyvinylidene diflouride membranes was confirmed by Ponceau S staining (Sigma, St. Louis, MO, USA, Data not shown). Anti-glyceraldehyde-3-phosphate dehydrogenase-antibody (GAPDH, mouse monoclonal, Imgenex, San Diego, CA, USA) and anti-bactin primary antibody (Bio-Rad Laboratories, Hercules, CA) were used as well to ensure that equal amounts of protein were applied to each lane. A loading control was not used for the CSF because GAPDH and b-actin were not detected in CSF.
Samples from the brain regions of each group were placed on the immunoblots to permit identical standard conditions among of the brain samples from the different reperfusion groups. However, for the purpose of the graphic illustration, we selected the specific immunoblots that the most closely represented the mean values for each bar graph of each group in Figures 1 and 2 . The white vertical lines were used to delineate the representative bands cut from the different immunoblots, for the entire immunoblots please see the Supporting Information Figure 1 . On the other hand, Figures 3-5 show the entire original immunoblots above the bar graphs.
Densitometric Analysis
Band intensities were analyzed with a Gel-Pro Analyzer (Media Cybernetics, Silver Spring, MD, USA). All experimental samples were normalized to the respective average autoradiographic IOD values of the three internal control samples. However, the band intensities were expressed as arbitrary autoradiographic IOD units for choroid plexus and 
Statistical Analysis
All results were expressed as means 6 standard error of the mean (SEM). Two-way analysis of variance (ANOVA) was used to compare the differences among the groups. The factors were ischemia-reperfusion (I/R) group (control, 4, 24, and 48 h I/R) and protein expression (125 kDa PaI and 250 kDa IaI). Two-way ANOVA was also used to determine the plasma concentrations over time among the study groups. If a significant effect of group was found by ANOVA, the Fisher least significant difference test was utilized to identify specific differences among the groups. A value of p < 0.05 was considered statistically significant.
RESULTS

IAIPs Detection by ELISA in Ovine Plasma
IAIPs were detected by our competitive ELISA in the fetal sheep plasma from the control and 4, 24 and 48 I/R groups. Serial samples were obtained just before and after the ischemic insults until the end of the studies at 4, 24, or 48 h after ischemia (Chen et al., 2012) . The baseline plasma levels did not differ among the groups (mean value for all groups: 156 6 5.8 mg/mL) and were not affected by the brain ischemia-reperfusion related insults after any of the different reperfusion exposure times.
IAIPs Detection by Western Immunoblot in Cerebral Cortex, Cerebellum, Choroid Plexus, Cervical Spinal Cord, and CSF IAIPs were detected in cerebral cortex, cerebellum, cervical spinal cord, choroid plexus, and CSF as the 125 kDa PaI and 250 kDa IaI protein bands by Western immunoblot using the specific antibody against IAIPs (Figs. 1-5 ). Human IAIPs were used as a positive control in each immunoblot as shown in Figure 1 and its location was identical in all immunoblot for each brain region. The expression of the PaI and IaI were both significantly lower in the cerebral cortex at 4 h after ischemia compared with the values in the sham control group. After 24 and 48 h of reperfusion, the values of PaI and IaI expression appeared to increase and return toward values that did not differ compared with the sham control group (Fig. 1) .
Likewise, the expression of the PaI in the cerebellum was reduced significantly in the group exposed to 4 h of reperfusion compared with the control group (Fig. 2) . However, although the IaI expression showed a similar pattern of change among the Inter-alpha inhibitor proteins and ischemiareperfusion groups, the SEM for this protein band was wide, and the changes did not show statistical significance. Likewise, the expressions of the PaI and IaI proteins did not exhibit statistically significant changes in the cervical spinal cord (Fig. 3) or in the choroid plexus (Fig. 4) .
Inspection of Figures 1-3 compared with Figure 5 suggests that the pattern of expression of IAIPs in the cerebral cortex, cerebellum, and spinal cord differed from those of the CSF. In CSF, the values of PaI and IaI expression after 4 and 24 h of reperfusion did not differ from the values in the control group. However, at 48 h after ischemia, the expression of the PaI protein was significantly lower compared with the control, 4-h, and 24-h reperfusion groups and the expression of the IaI protein was lower compared with the control and 24-h reperfusion groups (Fig. 5) .
DISCUSSION
The main purpose of our study was to examine the levels of IAIPs in the CNS after ischemic-reperfusion injury in fetal sheep as an initial approach to understand endogenous changes in these critical molecules after ischemic insults in fetal brain. Recently, we reported that IAIPs were identified for the first time in plasma, cerebral cortex, choroid plexus, CSF and other non-neural organs from early in fetal development through the neonatal period, and up to maturity in adult sheep as both the 125 kDa PaI and 250 kDa IaI IAIP protein moieties, and that IAIP genes and proteins are also present in fetal and neonatal rodent brain (Spasova et al., 2014; Chen et al., 2016) . Accordingly, we reasoned that the endogenous presence of both IAIP moieties in sheep and rodent brain over a wide span of development suggested that these proteins most likely have important immunomodulatory functions in normal brain (Fries and Blom, 2000; Lim et al., 2003) . Moreover, although the exact functions of the endogenous IAIPs in the CNS are not known, their presence in high amounts and in a wide variety of CNS cell types suggested a potentially important role in brain development and potentially injury repair (Spasova et al., 2014; Chen et al., 2016) .
The findings of our study are novel because previous work has not reported changes in the expression of IAIPs after ischemia in the CNS of any species. The major findings of this study were as follows. (1) Ischemia with reperfusion results in acute decreases in cerebral cortical and cerebellar IAIP levels 4 h after ischemia. (2) IAIP expressions return toward non-ischemic control levels 24 and 48 h after ischemia. (3) The expression of IAIPs in CSF remained similar to control levels at 4 and 24 h after the ischemic insult but exhibited a significant decrease 48 h after ischemia. (4) Serum IAIPs expression levels were not affected by brain ischemia.
Inflammation is increasingly recognized as an important factor in normal brain development and during the evolution of injury in the developing brain (Ferriero, 2004; Hagberg et al., 2012) . Although inflammation contributes to injury, it also participates in repair processes (Foster-Barber and Ferriero, 2002; Kendall and Peebles, 2005; Stridh et al., 2011; Hagberg et al., 2012; Hagberg et al., 2015) . Proinflammatory cytokines are important mediators in pathways associated with perinatal brain injury caused by a variety of insults including HI and inflammatory related brain damage (Dammann and O'Shea, 2008; Malaeb and Dammann, 2009; Elovitz et al., 2011; McAdams and Juul, 2012) . Moreover, we have previously shown that ischemia for 30 minutes with reperfusion for 48 and 72 h results in increases in IL-1b protein expression in the cerebral cortex of fetal sheep . In addition, we have shown that the high mobility group box 1 (HMGB1), which has recently been identified as a pro-inflammatory cytokine after extracellular release from necrotic tissue (Wang et al., 1999; Yang et al., 2005) , is translocated from the nucleus to the cytosolic compartment after ischemic brain injury in fetal sheep. Others have shown that hypoxia-ischemia also results in increases in caspase expression, microglia and gliosis in fetal sheep brain (Hutton et al., 2007; Riddle et al., 2011; . Therefore, there is evidence to suggest that inflammatory markers are increased in the brain of fetal sheep after hypoxia-ischemia.
In human neonates, sepsis, NEC, and mechanical ventilation are associated with increases in proinflammatory cytokines, cerebral palsy, and in lower mental and psychomotor development (Stoll et al., 2004; Shah et al., 2008; Bose et al., 2013; O'Shea et al., 2013) . IAIPs are decreased during systemic inflammation such as sepsis and NEC (Chaaban et al., 2009; Chaaban et al., 2010) and both disorders are associated with increased incidences of brain injury (Stoll et al., 2004; Shah et al., 2008) . These findings raise the interesting possibility that decreases in IAIPs could potentially contribute to the development of the associated brain injury (Stoll et al., 2004; Shah et al., 2008) .
IAIPs are anti-inflammatory proteins that inhibit destructive serine proteases, block pro-inflammatory cytokines, augment anti-inflammatory cytokine production, block complement activation during inflammation and neutralize the cytotoxicity of extracellular histones (Fries and Blom, 2000; Chaaban et al., 2015) . Furthermore, they are broad spectrum immunomodulators that increase survival after systemic infection, exhibit cytoprotective properties in somatic cells and CNS, and improve recovery after brain injury (Yano et al., 2003; Opal et al., 2005; Chaaban et al., 2009; Chaaban et al., 2010; Singh et al., 2010; Wang et al., 2013) . In addition, we have recently shown that exogenous IAIPs reduce cortical neuronal death, improve plasticity and behavioral outcomes in neonatal rats exposed to HI brain injury Gaudet et al., 2016) . Although there is a paucity of information regarding the characteristics and significance of endogenous IAIPs in the brain, recent evidence demonstrates that the Inter-alpha-Trypsin Inhibitor Heavy Chain 4 is decreased in the serum of human patients after acute ischemic stroke (Kashyap et al., 2009) . In contrast to the findings in adult patients after stroke (Kashyap et al., 2009) , ischemic-reperfusion brain injury was not associated with changes in the plasma IAIPs levels in our fetal sheep.
In the current study, we have shown that ischemia results in acute reductions in the endogeneous expression of IAIPs in fetal brain with levels returning toward control values 24 and 48 h after ischemia. Given that IAIPs decrease during systemic inflammation, and that inflammation is an important component of ischemia-reperfusion related brain injury, we speculate that the rapid decrease in IAIPs after ischemia suggests that these molecules are utilized, consumed and/or degraded as a result of the ischemiarelated inflammation in brain.
The increase in IAIPs after 24 and 48 h of reperfusion most likely represents local endogenous IAIPs synthesis within the brain parenchyma because IAIPs are relatively large molecules that most likely do not readily cross the fetal blood-brain barrier (Stonestreet et al., 1996) . Moreover, IAIPs are most likely readily produced within the brain parenchyma, because we have shown that they are widely expressed both in sheep and rodents during normal brain development and have shown the presence of IAIP genes in cultured mouse neurons (Spasova et al., 2014; Chen et al., 2016) .
Treatment with ulinastatin (bikunin) has been shown to have protective effects against ischemicreperfusion injury in the liver, intestine, kidney, heart, lung and brain (Li et al., 1993; Li et al., 1994; Nakahama et al., 1996; Yano et al., 2003) . Ulinastatin (bikunin) also has unique immunomodulatory effects by reducing TNF-a during reperfusion after ischemic injury and systemic inflammation (Li et al., 1993; Li et al., 1994; Nakahama et al., 1996) . Additionally, blood-derived IAIPs augment survival and exhibit anti-inflammatory properties in a model of neonatal sepsis (Singh et al., 2010) . Therefore, we postulate that endogenous IAIPs could also represent antiinflammatory molecules within the brain parenchyma that are consumed, utilized or deactivated by ishemia and resynthesized by brain shortly after ischemia as a component of endogenous reparative processes. Our current findings in conjunction with our recent publications would appear to suggest that IAIPs may function as endogenous protective factors, and also are efficacious when administered exogenously as a therapeutic treatment strategy Chen et al., 2016; Gaudet et al., 2016) . Therefore, it appears that both endogenous and exogenous IAIPs have important characteristics in brain injury. Hence, IAIPs could be analogous to other previously reported neuroprotective agents such as FGF-2, which has been shown to have endogenous protective functions and also to exert neuroprotective properties when given as an exogenous treatment strategy (Nozaki et al., 1993; Petersson et al., 2002; Noda et al., 2014) .
The function of the choroid plexus and its product CSF has been thought to provide physical protection to the brain and facilitate removal of brain metabolites through the drainage of CSF. However, more recent studies suggest that the choroid plexus and CSF play a much more active role in the development, homeostasis, and repair of the CNS (Bagnard et al., 2001; Johanson et al., 2008) . CSF is produced from choroid plexus as a plasma ultra-filtrate and from interstitial fluid drainage from CNS tissue. CSF also provides the CNS with a variety of biologically active growth, neurotrophic, and angiogenic factors essential for brain development (Bagnard et al., 2001; Johanson et al., 2008) and is also involved in responses to brain injury and subsequent repair processes (Bondy et al., 1992; Diaz-Ruiz et al., 1993; Gonzalez et al., 1995; Johanson et al., 1999; Raballo et al., 2000; Justicia et al., 2001; Reid and Ferretti, 2003; Sun et al., 2003; Chesnutt et al., 2004) . Previous studies have reported that many species including humans have very high CSF protein concentrations during the perinatal period that are most likely important for normal brain growth and development (Saunders, 1977; Dziegielewska et al., 1980; Dziegielewska et al., 1981; Dziegielewska et al., 1991; Dziegielewska et al., 2000; Iwama et al., 2000; Gato et al., 2001 ). In our previous study, we demonstrated high levels of IAIPs in the CSF of fetal sheep (Spasova et al., 2014) . The high protein concentrations in fetal CSF are most likely a result of local production by choroid plexus rather than immaturity of the blood-brain or blood-CSF barriers because both barriers form very early during development in the fetus (Saunders, 1977; Dziegielewska et al., 1980; Stonestreet et al., 1996; Johanson et al., 2011) . The IAIPs contained within the CSF most likely have important biological functions similar to growth factors and cytokines that could influence the development of neuroepithelial cells (Gato et al., 2004; Gato and Desmond, 2009; Johanson et al., 2011) . The delayed decreases in CSF IAIP levels 48 h after ischemia is of great interest and could represent ischemia-related interference with choroid plexus transport of IAIPs, even though the choroid plexus samples did not show significant reductions in IAIPs expression. Alternatively, the delayed reductions in CSF IAIP levels could also reflect corresponding reductions in interstitial fluid IAIP levels secondary to reduced IAIPs expression in the brain after ischemia.
The ubiquitous nature of IAIPs in multiple regions of sheep brain in including cerebral cortex, cerebellum, choroid plexus, and CSF during the development suggests that these molecules have important characteristics as endogenous anti-inflammatory molecules with region specific differential production or modulation during development (Spasova et al., 2014; Chen et al., 2016) . In addition, treatment with exogenous IAIPs during brain injury also has important neuroprotective properties Gaudet et al., 2016) . Future studies are required to examine the precise role of endogenous IAIPs in the brain and to determine the mechanisms by which exogenous IAIPs are neuroprotective . Furthermore, it would also be of great interest in future studies to examine the effect of ischemia on IAIPs at additional time intervals after ischemia, and to examine inflammatory changes as a function of changes in endogenous levels of IAIPs in the fetal sheep brain.
